Metformin was found to promote the formation of memory CD8+ T cells and inhibit their apoptosis, enabling increased tumor-infiltrating CD8+ T cells in lung cancer patients (Zhang et al., 2020). The gene discussed is CD8A; the disease is lung carcinoma.